benzocaine 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definition	Drug id	CAS RN
local anaesthetics	323	94-09-7

Description:

Molecule	Description
Molfile Inchi Smiles Synonyms: benzocaine norcaine 4-Carbethoxyaniline benzocaine hydrobromide benzocaine hydrochloride benzocaine HCl benzocaine methanesulfonate ethyl aminobenzoate parathesin americaine benzocaine formate	A surface anesthetic that acts by preventing transmission of impulses along NERVE FIBERS and at NERVE ENDINGS. Molecular weight: 165.19 Formula: C9H11NO2 CLOGP: 1.92 LIPINSKI: 0 HAC: 3 HDO: 1 TPSA: 52.32 ALOGS: -1.76 ROTB: 3

Molecule

Description

Molfile Inchi Smiles

Synonyms:

benzocaine
norcaine
4-Carbethoxyaniline
benzocaine hydrobromide
benzocaine hydrochloride
benzocaine HCl
benzocaine methanesulfonate
ethyl aminobenzoate
parathesin
americaine
benzocaine formate

A surface anesthetic that acts by preventing transmission of impulses along NERVE FIBERS and at NERVE ENDINGS.

Molecular weight: 165.19
Formula: C9H11NO2
CLOGP: 1.92
LIPINSKI: 0
HAC: 3
HDO: 1
TPSA: 52.32
ALOGS: -1.76
ROTB: 3

Drug dosage:

None

ADMET properties:

None

Approvals:

Date	Agency	Company	Orphan
None	FDA

FDA Adverse Event Reporting System (Female)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Irritable bowel syndrome	250.74	23.50	182	14315	82230	63392295
Gastrointestinal toxicity	219.36	23.50	78	14419	7663	63466862
Methaemoglobinaemia	217.65	23.50	59	14438	2344	63472181
Helicobacter infection	210.17	23.50	172	14325	92613	63381912
Pulmonary toxicity	204.15	23.50	78	14419	9377	63465148
Arthropathy	200.85	23.50	257	14240	234535	63239990
Ill-defined disorder	192.39	23.50	155	14342	81600	63392925
Muscle injury	184.43	23.50	138	14359	65207	63409318
Folliculitis	181.94	23.50	141	14356	70176	63404349
Blister	176.92	23.50	181	14316	129633	63344892
Pericarditis	169.48	23.50	178	14319	131401	63343124
Infection	158.01	23.50	226	14271	228947	63245578
Contusion	150.28	23.50	178	14319	149866	63324659
Duodenal ulcer perforation	147.61	23.50	137	14360	87072	63387453
Therapy non-responder	141.70	23.50	126	14371	75775	63398750
Impaired healing	136.05	23.50	141	14356	102401	63372124
Discomfort	127.08	23.50	173	14324	167201	63307324
Neoplasm malignant	124.00	23.50	80	14417	29781	63444744
C-reactive protein abnormal	118.21	23.50	92	14405	46004	63428521
Joint injury	117.33	23.50	77	14420	29495	63445030
Lower respiratory tract infection	114.69	23.50	146	14351	132161	63342364
Anti-cyclic citrullinated peptide antibody positive	106.69	23.50	132	14365	116080	63358445
Hepatic enzyme increased	106.19	23.50	176	14321	202152	63272373
Hepatotoxicity	106.14	23.50	79	14418	36962	63437563
Sleep disorder due to general medical condition, insomnia type	106.09	23.50	91	14406	52126	63422399
Gastrointestinal disorder	103.12	23.50	138	14359	131101	63343424
Stomatitis	95.69	23.50	137	14360	138588	63335937
Drug intolerance	82.84	23.50	203	14294	308458	63166067
Hypersensitivity	82.30	23.50	196	14301	292489	63182036
Synovitis	79.10	23.50	148	14349	186770	63287755
Hand deformity	78.66	23.50	135	14362	159322	63315203
Rheumatoid factor positive	77.62	23.50	96	14401	84310	63390215
Musculoskeletal pain	72.37	23.50	97	14400	92180	63382345
Treatment failure	71.36	23.50	147	14350	198896	63275629
Joint stiffness	71.19	23.50	66	14431	41803	63432722
Medication error	69.44	23.50	72	14425	52212	63422313
Nausea	67.40	23.50	58	14439	854413	62620112
Joint swelling	67.12	23.50	195	14302	327471	63147054
Systemic lupus erythematosus	66.48	23.50	147	14350	208771	63265754
Glossodynia	65.16	23.50	133	14364	178743	63295782
Pemphigus	62.70	23.50	133	14364	183593	63290932
Musculoskeletal stiffness	61.11	23.50	132	14365	184486	63290039
Swelling	60.36	23.50	168	14329	275210	63199315
Confusional state	58.65	23.50	151	14346	236229	63238296
Hip arthroplasty	53.41	23.50	60	14437	47586	63426939
Rheumatoid arthritis	52.82	23.50	152	14345	253667	63220858
Nasopharyngitis	52.66	23.50	152	14345	254105	63220420
Wound	52.04	23.50	115	14382	163148	63311377
Abdominal discomfort	50.12	23.50	174	14323	320711	63153814
Sleep disorder	48.21	23.50	75	14422	81491	63393034
Knee arthroplasty	47.16	23.50	60	14437	54146	63420379
Alopecia	46.74	23.50	176	14321	337360	63137165
Diarrhoea	43.63	23.50	60	14437	715306	62759219
Contraindicated product administered	43.01	23.50	128	14369	217520	63257005
Fall	41.29	23.50	19	14478	392315	63082210
Pruritus	40.89	23.50	177	14320	361276	63113249
Infusion related reaction	40.81	23.50	136	14361	245385	63229140
Peripheral swelling	39.58	23.50	142	14355	265800	63208725
Therapeutic product effect decreased	39.48	23.50	115	14382	193072	63281453
Swollen joint count increased	36.36	23.50	43	14454	36011	63438514
Drug hypersensitivity	35.77	23.50	153	14344	310534	63163991
Cough	34.34	23.50	12	14485	292731	63181794
Drug abuse	32.59	23.50	59	14438	72459	63402066
Rheumatic fever	31.77	23.50	44	14453	43067	63431458
Arthralgia	29.80	23.50	227	14270	569483	62905042
Hypotension	28.97	23.50	13	14484	272591	63201934
Completed suicide	27.17	23.50	84	14413	145589	63328936
Acute kidney injury	25.81	23.50	14	14483	263401	63211124
Vomiting	24.94	23.50	57	14440	559560	62914965
Malaise	24.17	23.50	36	14461	415918	63058607
Therapeutic product effect incomplete	24.14	23.50	73	14424	124983	63349542

FDA Adverse Event Reporting System (Male)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Methaemoglobinaemia	279.72	21.30	65	3140	3516	34950210
Drug abuse	246.40	21.30	137	3068	98959	34854767
Intentional product misuse	137.81	21.30	72	3133	45539	34908187
Toxicity to various agents	129.06	21.30	122	3083	200240	34753486
Serotonin syndrome	82.41	21.30	39	3166	19894	34933832
Completed suicide	79.06	21.30	68	3137	98100	34855626
Respiratory arrest	78.14	21.30	42	3163	28001	34925725
Hangover	41.23	21.30	11	3194	1040	34952686
Cardiac arrest	37.38	21.30	45	3160	96114	34857612
Intentional overdose	34.53	21.30	30	3175	43644	34910082
Overdose	34.38	21.30	42	3163	91017	34862709
Mydriasis	32.47	21.30	15	3190	7222	34946504
Cardio-respiratory arrest	28.52	21.30	30	3175	55243	34898483
Conjunctival scar	24.88	21.30	5	3200	134	34953592
Haemolysis	22.16	21.30	12	3193	8082	34945644

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Methaemoglobinaemia	447.42	19.26	117	13539	5440	79725292
Drug abuse	215.28	19.26	196	13460	162495	79568237
Irritable bowel syndrome	184.07	19.26	121	13535	62120	79668612
Helicobacter infection	167	19.26	119	13537	69585	79661147
Arthropathy	142.08	19.26	163	13493	176948	79553784
Pericarditis	130.73	19.26	122	13534	104114	79626618
Sleep disorder due to general medical condition, insomnia type	127.07	19.26	84	13572	43472	79687260
Blister	120.28	19.26	124	13532	119352	79611380
Ill-defined disorder	116.83	19.26	94	13562	65781	79664951
Discomfort	113.35	19.26	123	13533	125494	79605238
Stomatitis	107.53	19.26	129	13527	146628	79584104
Muscle injury	107.35	19.26	79	13577	48482	79682250
Systemic lupus erythematosus	106.47	19.26	117	13539	121032	79609700
Folliculitis	102.41	19.26	81	13575	55299	79675433
Contusion	99.66	19.26	125	13531	148651	79582081
Intentional product misuse	96.16	19.26	99	13557	95066	79635666
Duodenal ulcer perforation	93.75	19.26	83	13573	66128	79664604
Synovitis	92.08	19.26	121	13535	150613	79580119
Gastrointestinal toxicity	89.19	19.26	38	13618	8071	79722661
Sleep disorder	84.51	19.26	88	13568	85589	79645143
Toxicity to various agents	83.92	19.26	207	13449	421333	79309399
Respiratory arrest	83.18	19.26	73	13583	57477	79673255
Medication error	81.53	19.26	78	13578	68564	79662168
Completed suicide	79.35	19.26	147	13509	245620	79485112
Pulmonary toxicity	78.07	19.26	40	13616	12874	79717858
Therapy non-responder	77.37	19.26	87	13569	92218	79638514
Rheumatoid factor positive	76.82	19.26	71	13585	59768	79670964
Hepatic enzyme increased	74.29	19.26	121	13535	182489	79548243
Swelling	74.22	19.26	133	13523	216578	79514154
Impaired healing	70.71	19.26	81	13575	87574	79643158
Anti-cyclic citrullinated peptide antibody positive	69.05	19.26	78	13578	83065	79647667
Hypersensitivity	65.57	19.26	141	13515	262098	79468634
Hip arthroplasty	63.30	19.26	51	13605	35705	79695027
Hand deformity	61.22	19.26	82	13574	103837	79626895
Wound	59.95	19.26	86	13570	116093	79614639
Pemphigus	59.31	19.26	79	13577	99503	79631229
Glossodynia	58.53	19.26	80	13576	103257	79627475
Infection	58.17	19.26	128	13528	241584	79489148
Alopecia	53.96	19.26	121	13535	231234	79499498
Lower respiratory tract infection	53.02	19.26	86	13570	129134	79601598
Knee arthroplasty	52.96	19.26	50	13606	43198	79687534
C-reactive protein abnormal	51.88	19.26	52	13604	48315	79682417
Rheumatoid arthritis	50.83	19.26	111	13545	208359	79522373
Abdominal discomfort	50.69	19.26	124	13532	250603	79480129
Contraindicated product administered	49.23	19.26	93	13563	157445	79573287
Gastrointestinal disorder	45.67	19.26	78	13578	122127	79608605
Neoplasm malignant	45.24	19.26	40	13616	31770	79698962
Joint injury	41.79	19.26	38	13618	31297	79699435
Serotonin syndrome	40.39	19.26	44	13612	44983	79685749
Nausea	34.68	19.26	70	13586	957126	78773606
Fall	33.66	19.26	21	13635	487608	79243124
Therapeutic product effect decreased	31.97	19.26	80	13576	163783	79566949
Joint stiffness	31.67	19.26	37	13619	40793	79689939
Product dose omission issue	31.50	19.26	3	13653	247534	79483198
Musculoskeletal pain	31.43	19.26	60	13596	102294	79628438
Drug intolerance	31.38	19.26	108	13548	264011	79466721
Hepatotoxicity	30.95	19.26	41	13615	51311	79679421
Treatment failure	30.95	19.26	81	13575	170405	79560327
Cyanosis	30.60	19.26	29	13627	25153	79705579
Conjunctival scar	29.71	19.26	7	13649	210	79730522
Maternal exposure timing unspecified	29.49	19.26	16	13640	5776	79724956
Cardiac arrest	29.45	19.26	80	13576	172016	79558716
Sudden infant death syndrome	27.81	19.26	7	13649	278	79730454
Toxic anterior segment syndrome	27.27	19.26	12	13644	2752	79727980
Deep vein thrombosis postoperative	27.20	19.26	19	13637	10733	79719999
Hangover	26.93	19.26	11	13645	2101	79728631
Sinusitis	26.84	19.26	84	13572	195417	79535315
Autoimmune disorder	23.84	19.26	21	13635	16591	79714141
Pruritus	23.43	19.26	131	13525	394517	79336215
Intentional overdose	23.08	19.26	54	13602	105906	79624826
Diarrhoea	22.24	19.26	77	13579	880412	78850320
Cardio-respiratory arrest	22.24	19.26	54	13602	108456	79622276
Joint swelling	22.16	19.26	103	13553	288543	79442189
Acute kidney injury	21.41	19.26	35	13621	519369	79211363
Injection site ulcer	21.41	19.26	7	13649	712	79730020
Weight increased	21.30	19.26	99	13557	277287	79453445
Nasopharyngitis	21.28	19.26	93	13563	253788	79476944
Drug hypersensitivity	21.01	19.26	104	13552	298812	79431920
Neutropenia	20.37	19.26	12	13644	287698	79443034
Lower limb fracture	19.63	19.26	22	13634	23193	79707539
Musculoskeletal stiffness	19.41	19.26	70	13586	174938	79555794
Disease progression	19.34	19.26	4	13652	184358	79546374

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Source	Code	Description
ATC	C05AD03	CARDIOVASCULAR SYSTEM VASOPROTECTIVES AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE Local anesthetics
ATC	D04AB04	DERMATOLOGICALS ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. Anesthetics for topical use
ATC	N01BA05	NERVOUS SYSTEM ANESTHETICS ANESTHETICS, LOCAL Esters of aminobenzoic acid
ATC	R02AD01	RESPIRATORY SYSTEM THROAT PREPARATIONS THROAT PREPARATIONS Anesthetics, local
FDA CS	M0000728	Allergens
MeSH PA	D000777	Anesthetics
MeSH PA	D000779	Anesthetics, Local
MeSH PA	D002491	Central Nervous System Agents
MeSH PA	D002492	Central Nervous System Depressants
MeSH PA	D018373	Peripheral Nervous System Agents
MeSH PA	D018689	Sensory System Agents
FDA PE	N0000175629	Increased Histamine Release
FDA PE	N0000184306	Cell-mediated Immunity
FDA EPC	N0000185508	Standardized Chemical Allergen
CHEBI has role	CHEBI:48425	topical anesthetic
CHEBI has role	CHEBI:50904	alergeno
CHEBI has role	CHEBI:59683	antipruritic drugs
CHEBI has role	CHEBI:139492	sensitizers

Drug Use | Suggest Off label Use Form| |View source of the data|

Disease	Relation	SNOMED_ID	DOID
Tinea pedis	indication	6020002	DOID:12403
Cough	indication	49727002
Tinea corporis	indication	84849002
Sore throat symptom	indication	267102003
Skin irritation	indication	367466007
Local anesthesia	indication	386761002
Itching of skin	indication	418363000
Suppression of the Gag Reflex	indication
Tinea Infections	indication
Minor Skin Wound Pain	indication
Mouth Irritation	indication
Prevent Minor Bacterial Skin Infection	indication
Hypocalcemia	off-label use	5291005
Otalgia	off-label use	16001004
Impacted cerumen	off-label use	18070006
Osteoporosis	off-label use	64859006	DOID:11476
Postmenopausal osteoporosis	off-label use	102447009
Indigestion	off-label use	162031009
Renal Osteodystrophy with Hyperphosphatemia	off-label use
Gastritis	contraindication	4556007	DOID:4029
Suicidal thoughts	contraindication	6471006
Alcoholism	contraindication	7200002
Hyperammonemia	contraindication	9360008
Infectious gastroenteritis	contraindication	12463005
Hepatic encephalopathy	contraindication	13920009	DOID:13413
Constipation	contraindication	14760008	DOID:2089
Hypocupremia	contraindication	19577007
Herpes zoster auricularis	contraindication	21954000	DOID:9210
Sarcoidosis	contraindication	31541009	DOID:11335
Dehydration	contraindication	34095006
Depressive disorder	contraindication	35489007
Methemoglobinemia	contraindication	38959009	DOID:10783
Gastrointestinal ulcer	contraindication	40845000
Body fluid retention	contraindication	43498006
Conduction disorder of the heart	contraindication	44808001
Encephalitis	contraindication	45170000	DOID:9588
Disorder of cardiovascular system	contraindication	49601007	DOID:1287
Bleeding hemorrhoids	contraindication	51551000
Vitamin K deficiency	contraindication	52675005	DOID:11249
Nasal polyp	contraindication	52756005
Hepatic failure	contraindication	59927004
Perforation of tympanic membrane	contraindication	60442001
Diarrhea	contraindication	62315008
Blood coagulation disorder	contraindication	64779008	DOID:1247
Poisoning by phenobarbital	contraindication	64921004
Substance abuse	contraindication	66214007
Hypercalcemia	contraindication	66931009	DOID:12678
Hyperparathyroidism	contraindication	66999008	DOID:13543
Incontinence of feces	contraindication	72042002
Hepatic coma	contraindication	72836002	DOID:12550
Diabetes mellitus	contraindication	73211009	DOID:9351
Sleep apnea	contraindication	73430006	DOID:0050847
Factor II deficiency	contraindication	73975000
Appendicitis	contraindication	74400008	DOID:8337
Gastrointestinal hemorrhage	contraindication	74474003
Thrombotic thrombocytopenic purpura	contraindication	78129009	DOID:10772
Decreased respiratory function	contraindication	80954004
Herpes simplex	contraindication	88594005	DOID:8566
Kidney disease	contraindication	90708001	DOID:557
Thyrotoxicosis	contraindication	90739004	DOID:7997
Hemophilia	contraindication	90935002
Diaper rash	contraindication	91487003
Disorder of skin	contraindication	95320005	DOID:37
Disorder of mucous membrane	contraindication	95351003
Kidney stone	contraindication	95570007
Anemia due to enzyme deficiency	contraindication	111577008
Deficiency of glucose-6-phosphate dehydrogenase	contraindication	124134002	DOID:2862
Deficiency of cytochrome-b>5< reductase	contraindication	124184009
Open wound	contraindication	125643001
Gastrointestinal obstruction	contraindication	126765001
Seizure disorder	contraindication	128613002
Tuberculosis of ear	contraindication	186269001
Osteolysis	contraindication	203522001
Gastroesophageal reflux disease	contraindication	235595009	DOID:8534
Disease of liver	contraindication	235856003	DOID:409
Disorder of electrolytes	contraindication	237840007
Dyspnea	contraindication	267036007
Anemia	contraindication	271737000	DOID:2355
Eruption of skin	contraindication	271807003	DOID:0050486
Pregnancy, function	contraindication	289908002
Thrombocytopenic disorder	contraindication	302215000	DOID:1588
Neutropenic disorder	contraindication	303011007	DOID:1227
Viral ear infection	contraindication	312137007
Fungal ear infection	contraindication	312148000
Infective otitis media	contraindication	312218008
Cardiovascular event risk	contraindication	395112001
Breastfeeding (mother)	contraindication	413712001
Denuded skin	contraindication	418242004
Porphyria	contraindication	418470004
Fever greater than 100.4 Fahrenheit	contraindication	426000000

🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation level	Dissociation constant	Type (acidic/basic)
pKa1	2.5	Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

Target	Class	Pharos	UniProt	Action	Type	Activity value (-log[M])	Bioact source	MoA source
Sodium channel protein type 1 subunit alpha	Ion channel	P35498	SCN1A_HUMAN	BLOCKER			SCIENTIFIC LITERATURE	SCIENTIFIC LITERATURE
Sodium channel protein type 2 subunit alpha	Ion channel	Q99250	SCN2A_HUMAN	BLOCKER			SCIENTIFIC LITERATURE	SCIENTIFIC LITERATURE
Sodium channel protein type 3 subunit alpha	Ion channel	Q9NY46	SCN3A_HUMAN	BLOCKER			SCIENTIFIC LITERATURE	SCIENTIFIC LITERATURE
Sodium channel protein type 4 subunit alpha	Ion channel	P35499	SCN4A_HUMAN	BLOCKER			SCIENTIFIC LITERATURE	SCIENTIFIC LITERATURE
Sodium channel protein type 8 subunit alpha	Ion channel	Q9UQD0	SCN8A_HUMAN	BLOCKER			SCIENTIFIC LITERATURE	SCIENTIFIC LITERATURE
Sodium channel protein type 9 subunit alpha	Ion channel	Q15858	SCN9A_HUMAN	BLOCKER			SCIENTIFIC LITERATURE	SCIENTIFIC LITERATURE
Sodium channel protein type 11 subunit alpha	Ion channel	Q9UI33	SCNBA_HUMAN	BLOCKER			SCIENTIFIC LITERATURE	SCIENTIFIC LITERATURE
Sodium channel protein type 10 subunit alpha	Ion channel	Q9Y5Y9	SCNAA_HUMAN	BLOCKER			SCIENTIFIC LITERATURE	SCIENTIFIC LITERATURE
Sodium channel protein type 7 subunit alpha	Ion channel	Q01118	SCN7A_HUMAN	BLOCKER			SCIENTIFIC LITERATURE	SCIENTIFIC LITERATURE
Sodium channel protein type 5 subunit alpha	Ion channel	Q14524	SCN5A_HUMAN	BLOCKER	ED50	3.50	SCIENTIFIC LITERATURE	SCIENTIFIC LITERATURE

External reference:

ID	Source
4018117	VUID
N0000146455	NUI
D00552	KEGG_DRUG
1049105	RXNORM
C0005059	UMLSCUI
CHEBI:116735	CHEBI
CHEMBL278172	ChEMBL_ID
DB01086	DRUGBANK_ID
D001566	MESH_DESCRIPTOR_UI
2337	PUBCHEM_CID
3953	INN_ID
23239-88-5	SECONDARY_CAS_RN
U3RSY48JW5	UNII
199	MMSL
359	MMSL
4256	MMSL
387357002	SNOMEDCT_US
65020006	SNOMEDCT_US
4018117	VANDF
001366	NDDF

Pharmaceutical products:

Product	Category	Ingredients	NDC	Form	Quantity	Route	Marketing	Label
good sense vagicaineanti itch	HUMAN OTC DRUG LABEL	2	0113-0142	CREAM	20 g	TOPICAL	OTC monograph not final	13 sections
HurriCaine Topical Anesthetic	HUMAN OTC DRUG LABEL	1	0283-0220	GEL	200 mg	ORAL	OTC monograph not final	12 sections
HurriCaine Topical Anesthetic	HUMAN OTC DRUG LABEL	1	0283-0220	GEL	200 mg	ORAL	OTC monograph not final	12 sections
HurriCaineTopical Anesthetic Gel	HUMAN OTC DRUG LABEL	1	0283-0293	GEL	200 mg	ORAL	OTC monograph not final	12 sections
HurriCaineTopical Anesthetic Gel	HUMAN OTC DRUG LABEL	1	0283-0293	GEL	200 mg	ORAL	OTC monograph not final	12 sections
HurriCaineTopical Anesthetic Gel	HUMAN OTC DRUG LABEL	1	0283-0293	GEL	200 mg	ORAL	OTC monograph not final	12 sections
HurriCaineTopical Anesthetic Gel	HUMAN OTC DRUG LABEL	1	0283-0293	GEL	200 mg	ORAL	OTC monograph not final	12 sections
HurriCaineTopical Anesthetic Gel	HUMAN OTC DRUG LABEL	1	0283-0293	GEL	200 mg	ORAL	OTC monograph not final	12 sections
HurriCaine Topical Anesthetic	HUMAN OTC DRUG LABEL	1	0283-0520	GEL	200 mg	ORAL	OTC monograph not final	12 sections
HurriCaine Topical Anesthetic	HUMAN OTC DRUG LABEL	1	0283-0520	GEL	200 mg	ORAL	OTC monograph not final	12 sections
HurriCaineTopical Anesthetic	HUMAN OTC DRUG LABEL	1	0283-0522	GEL	200 mg	DENTAL	OTC monograph not final	12 sections
HurriCaineTopical Anesthetic Liquid	HUMAN OTC DRUG LABEL	1	0283-0569	LIQUID	200 mg	DENTAL	OTC monograph not final	12 sections
HurriCaineTopical Anesthetic Liquid	HUMAN OTC DRUG LABEL	1	0283-0569	LIQUID	200 mg	DENTAL	OTC monograph not final	12 sections
HurriCaine	HUMAN OTC DRUG LABEL	1	0283-0610	SPRAY	200 mg	DENTAL	OTC monograph not final	12 sections
HurriCaine	HUMAN OTC DRUG LABEL	1	0283-0610	SPRAY	200 mg	DENTAL	OTC monograph not final	12 sections
HurriCaineTopical Anesthetic	HUMAN OTC DRUG LABEL	1	0283-0622	GEL	200 mg	ORAL	OTC monograph not final	12 sections
HurriCaineTopical Anesthetic	HUMAN OTC DRUG LABEL	1	0283-0679	SPRAY	200 mg	ORAL	OTC monograph not final	11 sections
HurriCaineTopical Anesthetic	HUMAN OTC DRUG LABEL	1	0283-0679	SPRAY	200 mg	ORAL	OTC monograph not final	11 sections
HurriCaineTopical Anesthetic	HUMAN OTC DRUG LABEL	1	0283-0679	SPRAY	200 mg	ORAL	OTC monograph not final	11 sections
HurriCaine Topical Anesthetic	HUMAN OTC DRUG LABEL	1	0283-0871	GEL	200 mg	ORAL	OTC monograph not final	12 sections
HurriCaine Topical Anesthetic	HUMAN OTC DRUG LABEL	1	0283-0871	GEL	200 mg	ORAL	OTC monograph not final	12 sections
HurriCaine Topical Anesthetic	HUMAN OTC DRUG LABEL	1	0283-0871	GEL	200 mg	ORAL	OTC monograph not final	12 sections
HurriCaine Topical Anesthetic	HUMAN OTC DRUG LABEL	1	0283-0871	GEL	200 mg	ORAL	OTC monograph not final	12 sections
HurriCaine Topical Anesthetic	HUMAN OTC DRUG LABEL	1	0283-0871	GEL	200 mg	ORAL	OTC monograph not final	12 sections
HurriCaine Topical Anesthetic	HUMAN OTC DRUG LABEL	1	0283-0871	GEL	200 mg	ORAL	OTC monograph not final	12 sections
HurriCaineTopical Anesthetic Gel	HUMAN OTC DRUG LABEL	1	0283-0886	GEL	200 mg	ORAL	OTC monograph not final	12 sections
HurriCaineTopical Anesthetic Gel	HUMAN OTC DRUG LABEL	1	0283-0886	GEL	200 mg	ORAL	OTC monograph not final	12 sections
HurriCaineTopical Anesthetic Gel	HUMAN OTC DRUG LABEL	1	0283-0886	GEL	200 mg	ORAL	OTC monograph not final	12 sections
HurriCaine Topical Anesthetic	HUMAN OTC DRUG LABEL	1	0283-0914	SPRAY	200 mg	ORAL	OTC monograph not final	11 sections
HurriCaine Topical Anesthetic	HUMAN OTC DRUG LABEL	1	0283-0914	SPRAY	200 mg	ORAL	OTC monograph not final	11 sections